BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35485281)

  • 1. miR‑4730 suppresses the progression of liver cancer by targeting the high mobility group A1 pathway.
    Furuke H; Konishi H; Arita T; Kataoka S; Shibamoto J; Takabatake K; Takaki W; Shimizu H; Yamamoto Y; Morimura R; Komatsu S; Shiozaki A; Ikoma H; Otsuji E
    Int J Mol Med; 2022 Jun; 49(6):. PubMed ID: 35485281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA1 participates in MHCC97H cell proliferation and invasion through the ILK/Akt/GSK3β signaling pathway.
    Liu L; Zhang S; Hu L; Liu L; Guo W; Zhang J
    Mol Med Rep; 2017 Dec; 16(6):9287-9294. PubMed ID: 29152644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
    Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
    Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
    J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sevoflurane inhibits the proliferation and invasion of hepatocellular carcinoma cells through regulating the PTEN/Akt/GSK‑3β/β‑catenin signaling pathway by downregulating miR‑25‑3p.
    Cao Y; Lv W; Ding W; Li J
    Int J Mol Med; 2020 Jul; 46(1):97-106. PubMed ID: 32319540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
    Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
    Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PBX homeobox 1 enhances hair follicle mesenchymal stem cell proliferation and reprogramming through activation of the AKT/glycogen synthase kinase signaling pathway and suppression of apoptosis.
    Jiang Y; Liu F; Zou F; Zhang Y; Wang B; Zhang Y; Lian A; Han X; Liu Z; Liu X; Jin M; Wang D; Li G; Liu J
    Stem Cell Res Ther; 2019 Aug; 10(1):268. PubMed ID: 31443676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orai1, a Direct Target of microRNA-519, Promotes Progression of Colorectal Cancer via Akt/GSK3β Signaling Pathway.
    Deng W; Wang J; Zhang J; Cai J; Bai Z; Zhang Z
    Dig Dis Sci; 2016 Jun; 61(6):1553-60. PubMed ID: 26792278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA1 exacerbates tumor progression by activating miR-222 through PI3K/Akt/MMP-9 signaling pathway in uveal melanoma.
    Cheng Y; Cheng T; Zhao Y; Qu Y
    Cell Signal; 2019 Nov; 63():109386. PubMed ID: 31394192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway.
    Zhang J; Liu WL; Zhang L; Ge R; He F; Gao TY; Tian Q; Mu X; Chen LH; Chen W; Li X
    Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):50-57. PubMed ID: 30213289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-590 Suppresses Proliferation and Induces Apoptosis in Pancreatic Cancer by Targeting High Mobility Group A2.
    Wang YD; Mao JD; Wang JF; Xu MQ
    Technol Cancer Res Treat; 2020; 19():1533033820928143. PubMed ID: 32588766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1.
    Lu L; Zhang D; Xu Y; Bai G; Lv Y; Liang J
    Biomed Pharmacother; 2018 Aug; 104():613-621. PubMed ID: 29803174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
    Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
    Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
    Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
    Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
    Liau SS; Rocha F; Matros E; Redston M; Whang E
    Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-4317 suppresses the progression of hepatocellular carcinoma by targeting ZNF436-mediated PI3K/AKT signaling pathway.
    Zhang L; Chang S; Zhao Y; Cao G; Zhang D
    Tissue Cell; 2022 Feb; 74():101696. PubMed ID: 34861581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-124 suppresses growth and aggressiveness of osteosarcoma and inhibits TGF-β-mediated AKT/GSK-3β/SNAIL-1 signaling.
    Yu B; Jiang K; Zhang J
    Mol Med Rep; 2018 May; 17(5):6736-6744. PubMed ID: 29488603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma.
    Lan Y; Han J; Wang Y; Wang J; Yang G; Li K; Song R; Zheng T; Liang Y; Pan S; Liu X; Zhu M; Liu Y; Meng F; Mohsin M; Cui Y; Zhang B; Subash S; Liu L
    Cell Death Dis; 2018 Feb; 9(2):236. PubMed ID: 29445189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells.
    Panneerselvam J; Srivastava A; Muralidharan R; Wang Q; Zheng W; Zhao L; Chen A; Zhao YD; Munshi A; Ramesh R
    Oncotarget; 2016 Oct; 7(43):70247-70263. PubMed ID: 27602961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.